Scottsdale Scientific CEO, Dr. Stephen Levine, Ph.D., Lectures in London, England; Visit to UK Opens New Sales & Marketing Opportunities.Business Editors/Health Writers HAYWARD, Calif.--(BUSINESS WIRE)--Aug. 10, 2000 Highlighting an extensive spring and summer lecture schedule, Dr. Stephen Levine, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Scottsdale Scientific (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :STDS STDS System Transition and Deployment Strategy STDS Submarine Tactical Display System STDS Systems Technology Departmental Services STDS Studio Set ), addressed healthcare practitioners at Regent's Park
Nutritional supplements include vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other related products used to boost the nutritional content of the diet. to the professional market in the U.K. The daylong format gave Dr. Levine opportunity to review a wide range of topics and introduce new products in the Allergy Research Group line. While in England Dr. Levine also met with other distributors and clinicians, resulting in further invitations to lecture again next year in Europe. Of special note, preliminary discussions were held with Dr. Richard Dixey of Phytopharm PLC (LSE LSE - Language Sensitive Editor :PYM), a U.K. based pharmaceutical company with interest in the proprietary herbal formulas being developed by Scottsdale with Dr. Ba Hoang, M.D., Ph.D. On the seminar Michael Ash, B.Sc. D.O., N.D., Executive Director of Nutri-Link, Ltd. comments, "We are proud to represent Allergy Research Group in the U.K. and were most excited to present this workshop with Dr. Levine for our customers. He weaves theory and research into novel and comprehensible approaches that, using the products we have available, create successful treatment protocols. Providing our practitioners with a comprehensive range of new tools and ideas for treating their patients is a key element to expanding and retaining our customer base. We have had quite a lot of feedback from our customers thanking us for providing this opportunity. The seminar has already generated a substantial increase in sales and interest in Allergy Research Group products." Dr. Levine met extensively with Dr. Ash to discuss marketing and sales plans to support Nutri-Link's efforts on behalf of ARG See argument. arg - argument in the U.K. "I am very impressed with the business that Mr. Ash has created. At this time, Nutri-Link stands to do almost double the business they did with us last year. Europeans are historically known for their greater acceptance and use of natural products and they are an audience sophisticated enough to appreciate the superior quality of our line. I plan to come back to meet with our customers here again soon," said Levine. The U.K., along with the U.S.A., has seen a considerable growth in interest from the public in the use of dietary supplements and other non-conventional health programs. Datamonitor, which in 1996 estimated the U.K. market size for supplements at $178 million per year, extrapolated their research to 2001 and anticipate a conservative growth rate of 2.6% per year, producing a total gross recovery of $210 million. About Scottsdale Scientific, Inc. Scottsdale Scientific, Inc., through its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , Nutricology, Inc./Allergy Research Group, is an innovative leader in nutraceutical research and product formulation. Since its inception in 1979, the company has been noted for quality, hypoallergenic hy·po·al·ler·gen·ic adj. Having a decreased tendency to provoke an allergic reaction. hypoallergenic (hī´pōal´urjen´ik), adj nutritional supplements and supplies products to over 6,000 physicians and healthcare practitioners worldwide. The information contained in this news release, other than historical information, consists of forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such statements regarding the timing of acquiring and developing new products, of bringing them on line and of deriving revenues and profits from them, as well as the effects of those revenues and profits on the company's margins and financial position, is uncertain because many of the factors affecting the timing of those items are beyond the company's control. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion